SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Long-Term Efficacy and Safety of Zolpidem Extended-Release 12.5 mg, Administered 3 to 7 Nights Per Week for 24 Weeks, in Patients With Chronic Primary Insomnia: A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study
8 references·16 citing·43 second hop
Long-Term Efficacy and Safety of Zolpidem Extended-Release 12.5 mg, Administered 3 to 7 Nights Per Week for 24 Weeks, in Patients With Chronic Primary Insomnia: A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study (2008)Long-Term Efficacy and Safety of Zolpidem…An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia (2005)An evaluation of the efficacy…Sustained Efficacy of Eszopiclone Over 6 Months of Nightly Treatment: Results of a Randomized, Double-Blind, Placebo-Controlled Study in Adults with Chronic Insomnia (2003)Sustained Efficacy of Eszopic…Insomnia causes, consequences, and therapeutics: An overview (2003)Insomnia causes, consequences…Insomnia in Men—A 10-Year Prospective Population Based Study (2001)Insomnia in Men—A 10-Year Pro…Zolpidem (2000)ZolpidemDaytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. (1999)Daytime consequences and corr…Epidemiological Study on Insomnia in the General Population (1996)Epidemiological Study on Inso…A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. (1994)A multicenter, placebo-contro…Pharmacological Management of Insomnia (2021)Pharmacological Management of…Stress and sleep in college students prior to and during the COVID‐19 pandemic (2020)Stress and sleep in college s…Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2 (2020)Long-term efficacy and tolera…Antidepressants for insomnia in adults (2018)Antidepressants for insomnia …Tai Chi Chih Compared With Cognitive Behavioral Therapy for the Treatment of Insomnia in Survivors of Breast Cancer: A Randomized, Partially Blinded, Noninferiority Trial (2017)Tai Chi Chih Compared With Co…Sleep disturbances, TBI and PTSD: Implications for treatment and recovery (2015)Sleep disturbances, TBI and P…Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians (2015)Pharmacotherapy Treatment Opt…Insomnia: prevalence, consequences and effective treatment (2013)Insomnia: prevalence, consequ…Sleep and Antidepressant Treatment (2012)Sleep and Antidepressant Trea…Is exercise an alternative treatment for chronic insomnia? (2012)Is exercise an alternative tr…The association between insomnia and cardiovascular diseases (2010)The association between insom…Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia (2010)Efficacy and Safety of Doxepi…Chronic Insomnia: Clinical and Research Challenges - An Agenda (2010)Chronic Insomnia: Clinical an…Searching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics (2009)Searching for perfect sleep: …A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice (2009)A compendium of placebo-contr…Antidepressants for the Treatment of Insomnia (2008)Antidepressants for the Treat…Insomnia and Its Treatment (1985)Diagnostic and Statistical Manual of Mental Disorders (1988)Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? (1989)Spectral characteristics of sleep EEG in chronic insomnia (1998)An American Academy of Sleep Medicine Review (2000)SF-36: Evaluation of Quality of Life in Severe and Mild Insomniacs Compared With Good Sleepers (2001)Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies (2011)The Insomnia Severity Index: Psychometric Indicators to Detect Insomnia Cases and Evaluate Treatment Response (2011)Diagnostic and Statistical Manual of Mental Disorders (2013)Effect of exercise on sleep quality and insomnia in middle-aged women: A systematic review and meta-analysis of randomized controlled trials (2017)Genome-wide analysis of insomnia disorder (2018)Association between perceived stress and depression among medical students during the outbreak of COVID-19: The mediating role of insomnia (2021)A manual for standardized terminology, techniques and scoring system for sleep stages in human subjects (1968)The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research (1989)Epidemiology of insomnia: what we know and what we still need to learn (2002)Prevalence and impact of sleep disorders and sleep habits in the United States (2009)Temporal relations between sleep problems and both traumatic event exposure and PTSD: A critical review of the empirical literature (2009)Zolpidem for insomnia (2012)Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy (1994)Zaleplon (2000)Insomnia in the Elderly: Cause, Approach, and Treatment (2006)Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young Adults (1996)Behavioral and Pharmacological Therapies for Late-Life Insomnia (1999)Chronic Insomnia Is Associated with Nyctohemeral Activation of the Hypothalamic-Pituitary-Adrenal Axis: Clinical Implications (2001)Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures: ISPOR ePRO Good Research Practices Task Force Report (2008)Efficacy of Brief Behavioral Treatment for Chronic Insomnia in Older Adults (2011)Diagnostic and Statistical Manual of Mental Disorders (2013)Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial (2014)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis (2021)Comparative efficacy and acceptability of cognitive behavioral therapy delivery formats for insomnia in adults: A systematic review and network meta-analysis (2022)Management of Insomnia (2024)Prevalence of sleep disorders in the Los Angeles metropolitan area (1979)Insomnia in Young Men and Subsequent Depression: The Johns Hopkins Precursors Study (1997)Insomnia and global sleep dissatisfaction in Finland (2002)Insomnia and the risk of incident heart failure: a population study (2013)Effects of sleep changes on pain-related health outcomes in the general population: A systematic review of longitudinal studies with exploratory meta-analysis (2017)Work load and work hours in relation to disturbed sleep and fatigue in a large representative sample (2002)Insomnia: Epidemiology, characteristics, and consequences (2003)Validation of the Insomnia Severity Index in Primary Care (2013)New Drugs for Insomnia (2003)Evaluation of the Efficacy and Safety of Ramelteon in Subjects with Chronic Insomnia (2007)
this work references cited by second hop

References

  • 2003Sustained Efficacy of Eszopiclone Over 6 Months of Nightly Treatment: Results of a Randomized, Double-Blind, Placebo-Controlled Study in Adults with Chronic Insomnia630 cited
  • 1996Epidemiological Study on Insomnia in the General Population401 cited
  • 1999Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II.397 cited
  • 2000Zolpidem317 cited
  • 2003Insomnia causes, consequences, and therapeutics: An overview309 cited
  • 2001Insomnia in Men—A 10-Year Prospective Population Based Study264 cited
  • 2005An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia230 cited
  • 1994A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.223 cited

Cited by

  • 2013Insomnia: prevalence, consequences and effective treatment210 cited
  • 2018Antidepressants for insomnia in adults208 cited
  • 2017Tai Chi Chih Compared With Cognitive Behavioral Therapy for the Treatment of Insomnia in Survivors of Breast Cancer: A Randomized, Partially Blinded, Noninferiority Trial206 cited
  • 2010Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia192 cited
  • 2009A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

179 cited
  • 2020Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2178 cited
  • 2009Searching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics163 cited
  • 2020Stress and sleep in college students prior to and during the COVID‐19 pandemic147 cited
  • 2012Sleep and Antidepressant Treatment142 cited
  • 2015Sleep disturbances, TBI and PTSD: Implications for treatment and recovery134 cited
  • 2021Pharmacological Management of Insomnia132 cited
  • 2012Is exercise an alternative treatment for chronic insomnia?131 cited
  • 2010Chronic Insomnia: Clinical and Research Challenges - An Agenda112 cited
  • 2008Antidepressants for the Treatment of Insomnia108 cited
  • 2010The association between insomnia and cardiovascular diseases107 cited
  • 2015Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians101 cited